Aim: Recent studies have shown that some antihypertensive medications are associated
with a significant reduction in the incidence of Alzheimer's disease (AD). However, it remains …

Objective To explore the effects of telmisartan, an angiotensin II type 1 receptor blocker with
peroxisome proliferator-activated receptor γ-stimulating activity, on the levels of Aβ1-42 …

Background Therapeutic trials concerning the effect of antihypertensive therapy on cognition
have produced controversial findings. Our objective was to evaluate the impact of …

Observational studies suggest that angiotensin receptor blockers in hypertensive adults are
associated with lower post-mortem indicators of Alzheimer's disease pathology …

Hypertension (HT) and dementia are common disorders in the elderly. HT in the elderly is
associated with increased occurrence rates of dementia including Alzheimer′ s disease …

Introduction There is increasing evidence that hypertension may contribute to development
of dementia. Studies show that blood pressure lowering therapy might protect against …

Several studies report that blood pressure is increased in victims of Alzheimer's disease
(AD) decades before the onset of the disease. Years before onset of Alzheimer's disease …

We investigated whether angiotensin II receptor blockers (ARBs) and angiotensin converting
enzyme inhibitors (ACE-Is) are more strongly associated with Alzheimer's disease (AD) …

Chronic hypertension is associated with an increased risk of both vascular dementia and
Alzheimer's disease (AD). In this context, the role of anti-hypertensive therapy for the …

Background: It is unclear whether the main antihypertensive medication classes (diuretics,
calcium channel blockers, betablockers, angiotensin converting enzyme inhibitors, and …